Inflammatory markers for predicting overall survival in gastric cancer patients: A systematic review and meta-analysis
Open accessThe DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Abstract
Systemic inflammatory biomarkers have begun to be used in clinical practice to predict prognosis and survival of cancer patients, but the approach remains controversial. We conducted a meta-analysis to determine the predictive value of the c-reactive protein (CRP), neutrophil-to-lymphocyte ratio (NLR), and Glasgow prognostic score (GPS)/modified Glasgow prognostic score (mGPS) in the clinical outcome of gastric cancer (GC) patients. We searched literature databases to identify relevant studies. All articles identified in the search were independently reviewed based on predetermined selection criteria. Meta-analysis was conducted to calculate the hazard ratio (HR) and 95% confidence intervals (CI) of overall survival of the included studies. A total of 41 eligible cohort studies, involving a total of 18,348 patients meeting the inclusion criteria, were considered for meta-analysis. Increases in CRP (HR = 1.654, 95% CI: 1.272-2.151), NLR (HR = 1.605, 95% CI: 1.449-1.779), and GPS/mGPS (HR = 1.648, 95% CI: 1.351-2.011) were significantly associated with poorer survival in patients with GC. Substantial heterogeneities were noted in all three markers (I2 = 86.479%, 50.799%, 69.774%, in CRP, NLR, and GPS/mGPS, respectively). Subgroup analysis revealed a significant positive correlation between each marker and poor survival, regardless of country, study quality, cancer stage, study design, or the inclusion of patients undergoing chemotherapy. This meta-analysis demonstrates that CRP, NLR, and GPS/mGPS are associated with poor survival in patients with GC. Further prospective studies using standardized measurements are warranted to conclude the prognostic value of various inflammatory markers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
PRISMA-P Group, Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., & Stewart, L. A. (2015) · Systematic Reviews · doi:10.1186/2046-4053-4-1 · Cited by 26,223
Stang, A. (2010) · European Journal of Epidemiology · doi:10.1007/s10654-010-9491-z · Cited by 17,396
Borenstein, M., Hedges, L. V., Higgins, J. P. T., & Rothstein, H. R. (2021) · doi:10.1002/9781119558378 · Cited by 9,799
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment
Yu, H., Kortylewski, M., & Pardoll, D. (2007) · Nature Reviews Immunology · doi:10.1038/nri1995 · Cited by 1,804
The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancer
Guthrie, G. J. K., Charles, K. A., Roxburgh, C. S. D., Horgan, P. G., McMillan, D. C., & Clarke, S. J. (2013) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2013.03.010 · Cited by 1,552
Epidemiology of gastric cancer: global trends, risk factors and prevention
Rawla, P., & Barsouk, A. (2019) · Gastroenterology Review · doi:10.5114/pg.2018.80001 · Cited by 1,540
Inflammation and cancer: An ancient link with novel potentials
Perwez Hussain, S., & Harris, C. C. (2007) · International Journal of Cancer · doi:10.1002/ijc.23173 · Cited by 1,097
D2 Lymphadenectomy Alone or with Para-aortic Nodal Dissection for Gastric Cancer
Sasako, M., Sano, T., Yamamoto, S., Kurokawa, Y., Nashimoto, A., Kurita, A., Hiratsuka, M., Tsujinaka, T., Kinoshita, T., Arai, K., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707035 · Cited by 1,021
Systemic inflammation, nutritional status and survival in patients with cancer
McMillan, D. C. (2009) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32832a7902 · Cited by 1,001
Inflammation: Gearing the journey to cancer
KUNDU, J., & SURH, Y. (2008) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2008.03.002 · Cited by 803
Jablonska, J., Leschner, S., Westphal, K., Lienenklaus, S., & Weiss, S. (2010) · Journal of Clinical Investigation · doi:10.1172/jci37223 · Cited by 564
Dolcetti, R., Viel, A., Doglioni, C., Russo, A., Guidoboni, M., Capozzi, E., Vecchiato, N., Macrì, E., Fornasarig, M., & Boiocchi, M. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65436-3 · Cited by 480
Yamanaka, T., Matsumoto, S., Teramukai, S., Ishiwata, R., Nagai, Y., & Fukushima, M. (2007) · Oncology · doi:10.1159/000127412 · Cited by 454
Induction of interleukin-8 preserves the angiogenic response in HIF-1α–deficient colon cancer cells
Mizukami, Y., Jo, W.-S., Duerr, E.-M., Gala, M., Li, J., Zhang, X., Zimmer, M. A., Iliopoulos, O., Zukerberg, L. R., Kohgo, Y., et al. (2005) · Nature Medicine · doi:10.1038/nm1294 · Cited by 406
Characteristics of gastric cancer in Asia
Rahman, R. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i16.4483 · Cited by 404
High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer
Shimada, H., Takiguchi, N., Kainuma, O., Soda, H., Ikeda, A., Cho, A., Miyazaki, A., Gunji, H., Yamamoto, H., & Nagata, M. (2010) · Gastric Cancer · doi:10.1007/s10120-010-0554-3 · Cited by 381
Lord, B. I., Bronchud, M. H., Owens, S., Chang, J., Howell, A., Souza, L., & Dexter, T. M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.23.9499 · Cited by 329
The role of C-reactive protein as a prognostic indicator in advanced cancer
Mahmoud, F. A., & Rivera, N. I. (2002) · Current Oncology Reports · doi:10.1007/s11912-002-0023-1 · Cited by 325
Scott, H. R., McMillan, D. C., Forrest, L. M., Brown, D. J. F., McArdle, C. S., & Milroy, R. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600466 · Cited by 322
Lee, S., Oh, S. Y., Kim, S. H., Lee, J. H., Kim, M. C., Kim, K. H., & Kim, H.-J. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-350 · Cited by 281
Self-citationCrumley, A. B. C., McMillan, D. C., McKernan, M., McDonald, A. C., & Stuart, R. C. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602998 · Cited by 281
Jung, M. R., Park, Y. K., Jeong, O., Seon, J. W., Ryu, S. Y., Kim, D. Y., & Kim, Y. J. (2011) · Journal of Surgical Oncology · doi:10.1002/jso.21986 · Cited by 251
Cancer and Inflammation: Implications for Pharmacology and Therapeutics
Balkwill, F., & Mantovani, A. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.312 · Cited by 249
Miyamoto, R., Inagawa, S., Sano, N., Tadano, S., Adachi, S., & Yamamoto, M. (2018) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2018.02.003 · Cited by 239
Jiang, X., Hiki, N., Nunobe, S., Kumagai, K., Kubota, T., Aikou, S., Sano, T., & Yamaguchi, T. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.262 · Cited by 217
Liu, X., Sun, X., Liu, J., Kong, P., Chen, S., Zhan, Y., & Xu, D. (2015) · Translational Oncology · doi:10.1016/j.tranon.2015.06.006 · Cited by 212
Toiyama, Y., Miki, C., Inoue, Y., Tanaka, K., Mohri, Y., & Kusunoki, M. (2010) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2010.175 · Cited by 144
Potential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric Cancer
Tsai, M.-M., Wang, C., Tsai, C., Huang, H., Chi, H., Lin, Y.-H., Lu, P.-H., & Lin, K. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060945 · Cited by 140
Prognostic Factors in Advanced Gastrointestinal Cancer Patients With Weight Loss
O'Gorman, P., McMillan, D. C., & McArdle, C. S. (2000) · Nutrition and Cancer · doi:10.1207/s15327914nc3701_4 · Cited by 135
Macdonald, N. (2007) · PubMed · Cited by 134
Cho, I. R., Park, J. C., Park, C. H., Jo, J. H., Lee, H. J., Kim, S., Shim, C. N., Lee, H., Shin, S. K., Lee, S. K., et al. (2014) · Gastric Cancer · doi:10.1007/s10120-013-0330-2 · Cited by 124
Self-citationWang, D., Ren, C., Qiu, M., Luo, H., Wang, Z., Zhang, D.-S., Wang, F.-H., Li, Y.-H., & Xu, R. (2011) · Tumor Biology · doi:10.1007/s13277-011-0285-z · Cited by 122
Choi, Y., Kim, J. W., Nam, K. H., Han, S.-H., Kim, J., Ahn, S.-H., Park, D. J., Lee, K., Lee, H. S., & Kim, H. (2016) · Gastric Cancer · doi:10.1007/s10120-016-0642-0 · Cited by 116
Prognostic Significance of Host‐ and Tumor‐Related Factors in Patients with Gastric Cancer
Mohri, Y., Tanaka, K., Ohi, M., Yokoe, T., Miki, C., & Kusunoki, M. (2010) · World Journal of Surgery · doi:10.1007/s00268-009-0302-1 · Cited by 114
Huang, D., & Gao, Y. (2014) · Journal of Cancer Research and Therapeutics · doi:10.4103/0973-1482.146054 · Cited by 113
Zhang, X., Zhang, W., & Feng, L.-J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111906 · Cited by 111
Inflammation and Cancer: Is the Link as Simple as We Think?
Nickoloff, B. J., Ben-Neriah, Y., & Pikarsky, E. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23724.x · Cited by 110
Li, Q., Lü, Z., Yang, L., Lu, M. S., Zhang, X., Li, J., Zhou, J., Wang, X., Gong, J., Gao, J., et al. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.2.945 · Cited by 92
Hwang, J., Kim, H.-N., Kim, D.-E., Choi, H., Jung, S., Shim, H., Bae, W., Hwang, E. C., Cho, S., & Chung, I. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-489 · Cited by 90
Self-citationDutta, S., Crumley, A. B. C., Fullarton, G. M., Horgan, P. G., & McMillan, D. C. (2012) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2011.10.015 · Cited by 90
Saito, T., Kurokawa, Y., Miyazaki, Y., Makino, T., Takahashi, T., Yamasaki, M., Nakajima, K., Takiguchi, S., Mori, M., & Doki, Y. (2015) · Journal of Surgical Oncology · doi:10.1002/jso.24067 · Cited by 88
Dutta, S., Fullarton, G. M., Forshaw, M. J., Horgan, P. G., & McMillan, D. C. (2011) · World Journal of Surgery · doi:10.1007/s00268-011-1002-1 · Cited by 88
Hirashima, K., Watanabe, M., Shigaki, H., Imamura, Y., Ida, S., Iwatsuki, M., Ishimoto, T., Iwagami, S., Baba, Y., & Baba, H. (2013) · Journal of Gastroenterology · doi:10.1007/s00535-013-0855-5 · Cited by 86
(2009) · Introduction to Meta‐Analysis · doi:10.1002/9780470743386.ch12 · Cited by 85
Jeong, J.-H., Lim, S. M., Yun, J. Y., Rhee, G. W., Lim, J. Y., Choi, Y., & Kim, Y. R. (2012) · Oncology · doi:10.1159/000342376 · Cited by 82
Jiang, N., Deng, J., Liu, Y., Ke, B., Liu, H. G., & Liang, H. (2014) · Biomarkers · doi:10.3109/1354750x.2014.926567 · Cited by 80
Meta-analysis of associations between neutrophil-to-lymphocyte ratio and prognosis of gastric cancer
Chen, J., Hong, D., Zhai, Y., & Shen, P. (2015) · World Journal of Surgical Oncology · doi:10.1186/s12957-015-0530-9 · Cited by 76
Ishizuka, M., Oyama, Y., Abe, A., & Kubota, K. (2014) · Journal of Surgical Oncology · doi:10.1002/jso.23753 · Cited by 75
Mellor, K., Powell, A. G. M. T., & Lewis, W. G. (2018) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-018-0127-y · Cited by 74
Clinical Significance of Preoperative Inflammatory Parameters in Gastric Cancer Patients
Lee, D. Y., Hong, S. W., Chang, Y. G., Lee, W. Y., & Lee, B.-M. (2013) · Journal of the Korean Gastric Cancer Association · doi:10.5230/jgc.2013.13.2.111 · Cited by 62
Kubota, T., Hiki, N., Nunobe, S., Kumagai, K., Aikou, S., Watanabe, R., Sano, T., & Yamaguchi, T. (2012) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-012-2036-x · Cited by 60
Mao, M., Wei, X., Sheng, H., Chi, P., Liu, Y., Huang, X., Xiang, Y., Zhu, Q., Xing, S., & Liu, W. (2017) · Oncology Letters · doi:10.3892/ol.2017.7179 · Cited by 60
Wen, J., Bedford, M., Begum, R., Mitchell, H., Hodson, J. A., Whiting, J., & Griffiths, E. A. (2018) · Journal of Surgical Oncology · doi:10.1002/jso.25057 · Cited by 60
Is Gastric Cancer Again Rising?
Zhu, A. L., & Sonnenberg, A. (2012) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3182604254 · Cited by 59
Lieto, E., Galizia, G., AURICCHIO, A., Cardella, F., Mabilia, A., Basile, N., Sorbo, G. D., Castellano, P., Romano, C. P., Orditura, M., et al. (2017) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-017-3515-x · Cited by 56
Guo, J., Chen, S., Chen, Y., Li, S., & Xu, D. (2018) · Cancer Management and Research · doi:10.2147/cmar.s156071 · Cited by 54
Identification of prognostic factors and surgical indications for metastatic gastric cancer
Mohri, Y., Tanaka, K., Ohi, M., Saigusa, S., Yasuda, H., Toiyama, Y., Araki, T., Inoue, Y., & Kusunoki, M. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-409 · Cited by 53
Wu, J., Tan, W., Chen, L., Huang, Z., & Mai, S. (2018) · Oncotarget · doi:10.18632/oncotarget.24172 · Cited by 51
C-reactive protein is a potential prognostic factor for metastatic gastric cancer.
Shimura, T., Kitagawa, M., Yamada, T., Ebi, M., Mizoshita, T., Tanida, S., Kataoka, H., Kamiya, T., & Joh, T. (2012) · PubMed · Cited by 47
Melling, N., Grüning, A., Tachezy, M., Nentwich, M. F., Reeh, M., Uzunoglu, F. G., Vashist, Y. K., Izbicki, J. R., & Bogoevski, D. (2016) · Surgery · doi:10.1016/j.surg.2016.01.018 · Cited by 44
Aurello, P., Tierno, S. M., Berardi, G., Tomassini, F., Magistri, P., D’Angelo, F., & Ramacciato, G. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-3533-9 · Cited by 40
Prognostic Significance of Serum Inflammatory Markers in Gastric Cancer
Powell, A. G. M. T., Parkinson, D., Patel, N., Chan, D. S. Y., Christian, A. D., & Lewis, W. G. (2017) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-017-3597-5 · Cited by 34
C-reactive protein as a significant prognostic factor for stage IV gastric cancer patients.
Baba, H., Kuwabara, K., Ishiguro, T., Hatano, S., Matsuzawa, T., Fukuchi, M., Kumagai, Y., Ishibashi, K., Mochiki, E., & Ishida, H. (2013) · PubMed · Cited by 30
Sun, X., Wang, J., Liu, J., Chen, S., & Liu, X. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s108631 · Cited by 29
Evaluation of the staging systems for gastric cancer
Peng, C., Wang, L., Zeng, W., Yang, X., & Li, Y. (2013) · Journal of Surgical Oncology · doi:10.1002/jso.23360 · Cited by 27
Postoperative Serum C-Reactive Protein Level Predicts Long-term Outcomes in Stage I Gastric Cancer
Migita, K., Matsumoto, S., Wakatsuki, K., Kunishige, T., Nakade, H., Miyao, S., & Sho, M. (2019) · Journal of Surgical Research · doi:10.1016/j.jss.2019.04.075 · Cited by 26
Iwasa, S., Nakajima, T. E., Nakamura, K., Takashima, A., Kato, K., Hamaguchi, T., Yamada, Y., & Shimada, Y. (2010) · International Journal of Clinical Oncology · doi:10.1007/s10147-010-0135-9 · Cited by 25
Elevated serum C-reactive protein level predicts a poor prognosis for recurrent gastric cancer
Kong, F., Gao, F., Chen, J., Zheng, R., Liu, H., Li, X., Yang, P., Liu, G., & Jia, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.9910 · Cited by 25
Qu, J., Qu, X., Li, Z., Zhang, J., Liu, J., Teng, Y.-E., Jin, B., Zhao, M., Yu, P., Shi, J. C., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128540 · Cited by 22
Fujitani, K., Yamada, M., Hirao, M., Kurokawa, Y., & Tsujinaka, T. (2011) · Gastric Cancer · doi:10.1007/s10120-011-0053-1 · Cited by 22
Liu, J., Geng, Q., Chen, S., Liu, X., Kong, P., Zhou, Z., Zhan, Y., & Xu, D. (2016) · Oncotarget · doi:10.18632/oncotarget.8788 · Cited by 22
Yuan, S., Nie, R., Chen, Y., Qiu, H., Li, X., Chen, X., Xu, L., Yang, L., Sun, X., Li, Y., et al. (2018) · Oncology Letters · doi:10.3892/ol.2018.7826 · Cited by 22
Mimatsu, K., Oida, T., Fukino, N., Kano, H., Kawasaki, A., Kida, K., Kuboi, Y., & Amano, S. (2014) · PubMed · Cited by 20
Impact of systemic inflammation on gastric cancer outcomes
Liu, X., Chen, S., Liu, J., Xu, D., Li, W., Zhan, Y., Li, Y., Chen, Y., Zhou, Z., & Sun, X. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174085 · Cited by 19
Cited by
Kartikasari, A. E. R., Huertas, C. S., Mitchell, A., & Plebanski, M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.692142 · Cited by 343
He, K., Si, L., Pan, X., Sun, L. V., Wang, Y., Lu, J., & Wang, X. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.829689 · Cited by 116
Morphofunctional assessment of patient nutritional status: a global approach
García, C. G., Almeida, J. M. G., Vegas-Aguilar, I. M., Bellido, V., & Bellido, D. (2021) · Nutrición Hospitalaria · doi:10.20960/nh.03378 · Cited by 100
Schietroma, M., Romano, L., Schiavi, D., Pessia, B., Mattei, A., Fiasca, F., Carlei, F., & Giuliani, A. (2022) · Surgical Oncology · doi:10.1016/j.suronc.2022.101791 · Cited by 47
Shen, Y., Qian, L., Ding, Z., Luo, Q., Zhao, H., Xia, W.-Y., Fu, Y., Feng, W., Zhang, Q., Yu, W. J., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.711206 · Cited by 44
Metadata
- Authors
- Kim, M.-R., Kim, A.-S., Choi, H.-I., Jung, J.-H., Park, J. Y., & Ko, H.-J.
- Affiliations
- Kyungpook National University Hospital (KR)
- Kyungpook National University (KR)
- Corresponding author
- Ko, Hae-Jin
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2020-07-27
- Volume
- 15
- Issue
- 7
- Pages
- e0236445
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC7384660
- OpenAlex
- W3043868076
- Cited by
- 76
- References
- 77
- Citations by year
- 2026: 14 · 2025: 14 · 2024: 17 · 2023: 11 · 2022: 11 · 2021: 8
- FWCI
- 0.80
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
- Health Sciences › Medicine › Oncology › Gastric Cancer Management and Outcomes
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Keywords
- gastric cancer, inflammatory markers, C-reactive protein, neutrophil-to-lymphocyte ratio, Glasgow Prognostic Score, modified Glasgow Prognostic Score, overall survival, prognostic value, systemic inflammation
- MeSH terms
- C-Reactive Protein, Humans, Inflammation, Lymphocytes, Neutrophils, Prognosis, Stomach Neoplasms, Biomarkers, Survival Analysis, Publication Bias
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.